Richard Markus serves as Executive at Arcus Biosciences, Inc., where they oversee executive responsibilities. Since joining the company, Richard Markus has executed 4 insider transactions totaling $210.1K, demonstrating a bearish approach to their equity position. Their most recent transaction on Jan 23, 2026 involved receiving (via award) 96,000 shares valued at $0.
Richard Markus currently holds 96,000 shares of Arcus Biosciences, Inc. (RCUS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Richard Markus has been a net seller of RCUS stock. They have purchased $0 and sold $210.1K worth of shares.
Richard Markus's most recent insider trade was on Jan 23, 2026, when they sold 96,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Dec 17, 2025 | RCUS | $99.6K | Sale | 4,494 | $22.16 | Discretionary |
| Dec 16, 2025 | RCUS | $110.5K | Sale | 5,052 | $21.88 | Discretionary |